These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23066853)

  • 21. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the accuracy and performance of implicit solvent models for drug molecules: conformational ensemble approaches.
    Kolář M; Fanfrlík J; Lepšík M; Forti F; Luque FJ; Hobza P
    J Phys Chem B; 2013 May; 117(19):5950-62. PubMed ID: 23600402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling and Prediction of Solvent Effect on Human Skin Permeability using Support Vector Regression and Random Forest.
    Baba H; Takahara J; Yamashita F; Hashida M
    Pharm Res; 2015 Nov; 32(11):3604-17. PubMed ID: 26033768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches.
    Chen M; Yang J; Tang C; Lu X; Wei Z; Liu Y; Yu P; Li H
    Curr Top Med Chem; 2024; 24(3):222-242. PubMed ID: 38083894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of GAFF2 and OPLS-AA General Force Fields in Combination with the Water Models TIP3P, SPCE, and OPC3 for the Solvation Free Energy of Druglike Organic Molecules.
    Vassetti D; Pagliai M; Procacci P
    J Chem Theory Comput; 2019 Mar; 15(3):1983-1995. PubMed ID: 30694667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of topochemical models for the prediction of permeability through the blood-brain barrier.
    Dureja H; Madan AK
    Acta Pharm; 2007 Dec; 57(4):451-67. PubMed ID: 18165189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.
    Radan M; Djikic T; Obradovic D; Nikolic K
    Eur J Pharm Sci; 2022 Jan; 168():106056. PubMed ID: 34740787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confident application of a global human liver microsomal activity QSAR.
    Stålring J; Sohlenius-Sternbeck AK; Terelius Y; Parkes K
    Future Med Chem; 2018 Jul; 10(13):1575-1588. PubMed ID: 29953260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
    Ivanciuc O
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-permeability profiles for drug substances: Experimental detection, comparison with human intestinal absorption and modelling.
    Oja M; Maran U
    Eur J Pharm Sci; 2018 Oct; 123():429-440. PubMed ID: 30100533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers.
    Lanevskij K; Didziapetris R
    J Pharm Sci; 2019 Jan; 108(1):78-86. PubMed ID: 30321548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding Passive Membrane Permeation of Peptides: Physical Models and Sampling Methods Compared.
    Mazzanti L; Ha-Duong T
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extension of the free energy workflow FEW towards implicit solvent/implicit membrane MM-PBSA calculations.
    Homeyer N; Gohlke H
    Biochim Biophys Acta; 2015 May; 1850(5):972-982. PubMed ID: 25450172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting small-molecule solvation free energies: an informal blind test for computational chemistry.
    Nicholls A; Mobley DL; Guthrie JP; Chodera JD; Bayly CI; Cooper MD; Pande VS
    J Med Chem; 2008 Feb; 51(4):769-79. PubMed ID: 18215013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
    Shinde RN; Srikanth K; Sobhia ME
    J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the SAMPL5 host-guest challenge: Are we doing better?
    Yin J; Henriksen NM; Slochower DR; Shirts MR; Chiu MW; Mobley DL; Gilson MK
    J Comput Aided Mol Des; 2017 Jan; 31(1):1-19. PubMed ID: 27658802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.